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Changes in plasma C1q, apelin 
and adropin concentrations 
in older adults after descending 
and ascending stair walking 
intervention
Trevor C. Chen 1*, Tsang‑Hai Huang 2, Wei‑Chin Tseng3, Kuo‑Wei Tseng3, 
Chung‑Chan Hsieh1, Mei‑Yen Chen 4, Tai‑Ying Chou5, Yuh‑Chuan Huang6, Hsin‑Lian Chen7 & 
Kazunori Nosaka 8
This study compared changes in plasma complement component 1q (C1q), apelin and adropin 
concentrations in older obese women after descending (DSW) and ascending stair walking (ASW) 
training (n = 15/group) performed twice a week for 12 weeks, with gradual increases in exercise time 
from 5 to 60 min. Fasting blood samples were collected 3 days before the first and 4 days after the last 
training session. The improvements in the maximal voluntary isometric contraction (MVIC) strength 
of the knee extensors, functional physical fitness [e.g., 30‑s chair stand (CS) performance], resting 
systolic blood pressure (SBP), insulin sensitivity [e.g., oral glucose tolerance test (OGTT)] and blood 
lipid profiles [e.g., total cholesterol (TC)] were greater (p < 0.05) in the DSW than ASW group. Plasma 
C1q decreased (− 51 ± 30%), and apelin (23 ± 15%) and adropin (127 ± 106%) increased (p ≤ .0.05) 
only after DSW. Significant (p ≤  0.01) partial correlations were found between the pre‑ to post‑DSW 
changes in C1q, apelin or adropin and changes in outcome measures [e.g., C1q and MVIC (r = − 0.837), 
apelin and SBP (r = − 0.854), and andropin and OGTT (r = − 0.729)]. These results showed that greater 
decreases in plasma C1q and greater increases in apelin and adropin concentrations were associated 
with greater improvements in outcome measures after DSW than after ASW.
It is recommended that individuals engage in 150 to 300 min of moderate intensity physical activity, 75 to 150 min 
of vigorous-intensity physical activity, or an equivalent combination of both moderate and vigorous activities 
each week and muscle strengthening activities at least two days each  week1,2. However, only 22% of adults meet 
these recommendations, and the number decreases with increasing  age3. Physical inactivity is a cause of many 
chronic  diseases4, and regular exercise is key for increasing health span, quality of life and well-being5. Thus, 
exercises that more efficient and effective in achieving these outcomes should be implemented, and it appears 
that muscle contraction type is a factor affecting these outcomes.
A previous study showed that resistance training emphasising eccentric (lengthening) contractions of the 
knee extensors once a week for 12 weeks increased knee extension muscle strength, functional physical fitness 
such as the ability to stand up and sit down in a chair as quickly as possible for 30 s, insulin sensitivity and blood 
lipid profiles in older men greater than training emphasising concentric (shortening)  contractions6. Another 
study found that descending stair walking (DSW), in which the knee extensors predominantly undergo eccentric 
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contractions, twice a week for 12 weeks was also more effective in improving muscle strength, functional physical 
fitness, blood pressure, insulin sensitivity and blood lipid profiles in older obese women than ascending stair 
walking (ASW), in which the knee extensors mainly undergo concentric  contractions7. However, it is not known 
why exercise training involving eccentric contractions (i.e., eccentric training) produces greater adaptations of 
not only the muscles that are stimulated during the training but also other organs in the body to improve blood 
pressure, insulin sensitivity and blood lipid  profiles6,8. It may be that changes in some biomarkers induced by 
exercise training involving eccentric contractions (e.g., DSW) and that involving concentric contractions (e.g., 
ASW) are different.
Some studies have shown that the expression of complement component 1q (C1q), which is a protein complex 
involved in the innate immune  system9, increases with age and leads to muscle fibrosis and  atrophy10,11. Previ-
ous  studies12,13 have reported that C1q expression in the blood is a marker of sarcopenia and that the higher the 
concentration of C1q is in the blood, the greater the extent of sarcopenia. Watanabe et al.13 reported that 12 weeks 
of resistance training of the knee flexors and extensors three times a week with a load of 70% one-repetition 
maximal (1-RM) consisting of 3 sets of 10 repetitions per session decreased the serum C1q concentration by 39%, 
and increased maximal voluntary isometric contraction (MVIC) strength by 8–12% and muscle cross-sectional 
area by 7% in older adults. Thus, it may be that eccentric exercise training decreases the C1q concentration in 
the blood more than concentric exercise training.
Apelin is produced and secreted by adipose  tissue14 and affects various physiological processes, including 
modulating cardiovascular function and glucose homeostasis, promoting insulin sensitivity and modulating 
energy metabolism, lipogenesis and  lipolysis15. Kadoglou and  colleagues16 found significant increases in the 
serum apelin concentration (+ 39%) after 12 weeks of aerobic exercise training in patients with type 2 diabetes 
mellitus (T2DM). Afshounpour and  colleagues17 also showed that the plasma apelin concentration increased by 
29% and that this increase was accompanied by improved insulin resistance after 8 weeks of aerobic and whole-
body resistance exercise training in patients with T2DM. It is possible that eccentric exercise training increases 
the apelin concentration in the blood more than concentric exercise training.
Adropin is known as a regulator of endothelial nitric oxide (NO) synthase and NO release, and the circulating 
adropin concentration decreases with  age18,19. Fujie and  colleagues19 reported that the serum adropin concentra-
tion increased by 80% in middle-aged and older individuals after 8 weeks of aerobic cycling training three times 
per week and that the increase in the serum adropin concentration was significantly correlated with a decrease 
in carotid beta-stiffness and an increase in the plasma NO concentration. It might be that changes in the adropin 
concentration in the blood are greater after eccentric exercise training than concentric exercise training.
As mentioned above, we found that knee extensor MVIC strength (34%) and physical function (8–42%) were 
increased, systolic blood pressure (SBP) was decreased by 9%, and insulin sensitivity [e.g., oral glucose tolerance 
test (OGTT) results: − 12%] and lipid profiles [e.g., low-density lipoprotein cholesterol (LDLC) level: − 13%] were 
improved in elderly obese women who performed DSW twice a week for 12 weeks with a progressive increase 
in repetitions from two (110 steps × 2 = 220 steps) to 24 (110 steps × 24 = 2,640 steps) compared with those who 
performed ASW (15%, 4–22%, − 2% and − 7%, respectively)7. We hypothesised that the plasma C1q concentra-
tion would decrease to a greater extent and that apelin and adropin concentrations would increase to a greater 
extent after DSW training than after ASW training. To test this hypothesis, we used the stored blood samples 
from our previous  study7 to measure C1q, apelin and adropin concentrations in stored plasma samples taken at 
baseline and after the 12-week DSW and ASW  interventions7, compared the changes in concentrations between 
the DSW and ASW groups, and investigated the relationships between the changes in the blood markers and the 
changes in musculoskeletal parameters, functional physical fitness, cardiovascular function (resting heart rate 
(HR) and blood pressure), insulin sensitivity and lipid profiles, which had been evaluated in our previous  study7.
Results
Baseline measurements. No significant (p > 0.05) differences in any of the outcome measures (Tables 1, 
2) or for plasma C1q, apelin and adropin concentrations were found between the DSW and ASW groups (Fig. 1) 
at the baseline.
Changes in outcome measures. Significant differences in the changes in resting heart rate (HR) and 
SBP were found between the DSW and ASW groups, with the DSW group showing a greater decrease than 
the ASW group (HR: interaction effect: p = 0.003, η2 = 0.480; SBP: p = 0.018, η2 = 0.341; Table 1). Significantly 
(p ≤ 0.05) greater improvements in the MVIC strength of the knee extensors (p < 0.001, η2 = 0.653), upper thigh 
circumference (CIR; p = 0.024, η2 = 0.313), and calcaneal bone mineral density (BMD) of the right heel (p = 0.002, 
η2 = 0.499) were also evident after DSW training than after ASW training (Table 1). Significant (p ≤ 0.05) improve-
ments in performance in all functional physical fitness tests were observed in both the DSW and ASW groups 
following the 12-week training, but the magnitude of the improvements in performance in the 30-s chair stand 
(CS) test p = 0.007, η2 = 0.420), balance with eyes closed on an unstable surface (ECUS; p < 0.001, η2 = 0.742) and 
balance with eyes open on a firm surface (EOFS; p < 0.001, η2 = 0.585) was greater (p ≤ 0.05) after DSW training 
than after ASW training, as shown in Table 1. As shown in Table 2, significantly (p ≤ 0.05) greater changes in 
all insulin sensitivity (e.g., glucose concentration: p = 0.042, η2 = 0.263) and lipid profile (e.g., triglyceride (TG) 
concentration: p = 0.013, η2 = 0.365) parameters were found after DSW training than after ASW training.
Changes in plasma C1q, apelin, and adropin concentrations. After 12-week DSW training, the 
plasma C1q concentration decreased [p < 0.001, eta-squared values (η2) = 0.599], and the apelin (p < 0.001, 
η2 = 0.767) and adropin (p = 0.003, η2 = 0.480) concentrations increased, but no significant changes were found 
after ASW training (C1q concentration: p = 0.885, η2 = 0.002; apelin concentration: p = 0.267, η2 = 0.087; adropin 
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Table 1.  Changes (mean ± SD) between the pre- and post-training time points in the ascending (ASW; n = 15) 
and descending stair walking (DSW; n = 15) groups for body mass, body mass index (BMI), percent body 
fat, resting heart rate (HR), systolic (SBP) and diastolic blood pressure (DBP), maximal voluntary isometric 
contraction strength of the knee extensors (MVIC), performance in the 30-s chair stand (CS), 2-min step 
(2MS), 6-m walk (6 MW), 6-m tendon walk (TW) test, balance with eyes open on firm surface (EOFS), 
balance with eyes closed on unstable surface (ECUS), upper thigh circumference (CIR), and bone mineral 
density (BMD). # : significant (p ≤ 0.05) difference compared with the pre-training level. *: significant (p ≤ 0.05) 
difference compared with the ASW group.
Group Pre Post Group Pre Post Group Pre Post
Body mass (kg)
ASW 62.7 ± 6.4 62.1 ± 5.9#
BMI (kg/m2)
ASW 26.1 ± 0.8 25.8 ± 0.7#
Body fat (%)
ASW 34.6 ± 5.3 33.4 ± 4.8#
DSW 62.8 ± 5.1 61.7 ± 5.2# DSW 26.2 ± 1.1 25.7 ± 1.1# DSW 36.4 ± 3.3 35.1 ± 3.4#
HR (beats/min)
ASW 80.3 ± 4.7 77.1 ± 5.1#
SBP (mmHg)
ASW 122.6 ± 11.7 118.5 ± 12.4#
DBP (mmHg)
ASW 69.3 ± 7.7 65.6 ± 7.5#
DSW 79.2 ± 4.5 71.5 ± 6.2#,* DSW 119.9 ± 9.3 109.7 ± 10.8#,* DSW 69.1 ± 7.2 64.1 ± 7.1#
MVIC (N)
ASW 245.3 ± 29.4 280.5 ± 27.3#
CS (times)
ASW 16.5 ± 1.4 19.9 ± 1.6#
2MS (times)
ASW 111.0 ± 5.1 118.9 ± 6.0#
DSW 262.4 ± 25.5 352.2 ± 55.7#,* DSW 15.0 ± 1.3 21.3 ± 3.5#,* DSW 110.1 ± 4.7 122.2 ± 14.5#
6 MW (m)
ASW 467.0 ± 38.9 482.6 ± 34.2#
TW (s)
ASW 27.1 ± 4.2 24.0 ± 2.7#
EOFS (SI)
ASW 0.69 ± 0.06 0.64 ± 0.07#
DSW 460.1 ± 31.3 496.1 ± 41.6# DSW 26.3 ± 4.0 21.6 ± 4.7# DSW 0.68 ± 0.05 0.52 ± 0.09#,*
ECUS (SI)
ASW 2.86 ± 0.20 2.72 ± 0.31#
CIR (cm)
ASW 48.1 ± 3.7 48.4 ± 3.6#
BMD (m/s)
ASW 1492.3 ± 66.3 1496.8 ± 36.1
DSW 2.88 ± 0.25 2.08 ± 0.43#,* DSW 48.6 ± 2.6 49.2 ± 2.5# DSW 1487.5 ± 55.3 1576.9 ± 69.7#,*
Table 2.  Changes (mean ± SD) in resting glucose (GLU) and insulin (INS) concentrations, the homeostasis 
model assessment (HOMA) index, whole blood glycosylated hemoglobin (HbA1c) concentration, oral glucose 
tolerance test (OGTT) results, total cholesterol (TC), triacylglycerol (TG), low- (LDLC) and high-density 
lipoprotein cholesterols (HDLC) concentrations before (pre) and after (post) ascending (ASW; n = 15) and 
descending stair walking (DSW; n = 15). # : significant (p ≤ 0.05) difference compared with the pre-training level. 
*: significant (p ≤ 0.05) difference compared with the ASW group.
Group pre post Group pre post Group pre post
GLU (mg/dL)
ASW 111.5 ± 6.9 106.4 ± 6.6#
INS (pmol/L)
ASW 83.3 ± 6.9 79.1 ± 5.6#
HOMA (A.U.)
ASW 2.64 ± 0.32 2.39 ± 0.24#
DSW 113.9 ± 15.5 104.2 ± 18.4#,* DSW 85.4 ± 7.1 69.2 ± 5.3#,* DSW 2.74 ± 0.32 2.02 ± 0.28#,*
HbA1c (%)
ASW 5.86 ± 0.35 5.88 ± 0.65
OGTT (mg/dL/2 h)
ASW 816.4 ± 69.6 798.6 ± 86.1#
TG (md/dL)
ASW 105.9 ± 8.6 97.9 ± 11.3#
DSW 5.87 ± 0.27 5.58 ± 0.38#,* DSW 833.7 ± 61.8 733.6 ± 80.5#,* DSW 109.3 ± 8.4 88.1 ± 19.6#,*
TC (md/dL)
ASW 208.5 ± 18.5 201.1 ± 14.8#
LDLC (md/dL)
ASW 125.9 ± 12.5 116.0 ± 7.9#
HDLC (md/dL)
ASW 64.4 ± 6.1 64.2 ± 5.9
DSW 215.2 ± 20.3 194.5 ± 24.9# DSW 127.5 ± 11.9 110.5 ± 13.3#,* DSW 62.1 ± 5.7 68.3 ± 7.4#,*
Figure 1.  Changes (individuals, mean ± SD) in plasma complement component 1q (C1q) (a), apelin (b) and 
adropin (c) concentrations before (pre) and after (post) 12 weeks of descending (DSW) and ascending stair 
walking (ASW) interventions. *Significant change (p ≤ 0.05) compared to the baseline (pre) level in each group; 
ns: no significant difference (p ≥ 0.05) from the baseline (pre) level; #Significant difference (p ≤ 0.05) compared to 
the post-intervention level in the ASW group.
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concentration: p = 0.165, η2 = 0.133) (Fig.  1). The magnitude of the decrease in C1q concentration (p < 0.001, 
η2 < 0.600) and the increase in apelin (p = 0.011, η2 = 0.378) and adropin (p = 0.014, η2 = 0.361) concentrations 
between the pre- to post-training time points was greater in the DSW group than in the ASW group (Fig. 1).
Correlations between changes in C1q, apelin or adropin concentrations and changes in out‑
come measures. Table 3 shows the results of partial correlation analyses of the magnitude of changes in 
plasma C1q, apelin, and adropin concentrations and the changes in HR, blood pressure, muscle strength, func-
tional physical fitness, muscle and bone, insulin sensitivity, and lipid profile parameters from baseline to the 
post-training time point for participants in the DSW group. The normalised change in C1q concentration was 
significantly (p ≤ 0.01) correlated with the changes in MVIC (Fig. 2a), upper thigh circumference (Fig. 2b), 6-m 
walk (6 MW) test results and calcaneal BMD between the pre- to post-training time point in the DSW group. 
The normalised change in apelin concentration was significantly (p ≤ 0.01) correlated with the changes in SBP 
(Fig. 2c), diastolic blood pressure (DBP) (Fig. 2d) and 6 MW test results between pre- to post-training time 
points in the DSW group. The normalised change in adropin concentration was also significantly (p ≤ 0.01) 
correlated with the changes in balance with EOFS, serum glucose concentration, homeostasis model assess-
ment (HOMA) index, OGTT results (Fig. 2e), total cholesterol (TC) concentration and high-density lipoprotein 
cholesterol (HDLC) concentration (Fig. 2f). In the ASW group, a significant (p ≤ 0.01) correlation was between 
changes in the apelin concentration and changes in DBP (r = − 0.732, p = 0.008), between changes in the apelin 
concentration and changes in CS (r = − 0.717, p = 0.010), and between changes in the apelin concentration and 
changes in glycosylated haemoglobin (HbA1c) concentration (r = 0.762, p = 0.005) only.
Discussion
The main findings of the present study were that (1) changes in plasma C1q, apelin and adropin contractions were 
greater after DSW training than after ASW training (Fig. 1); (2) the magnitude of decrease in the plasma C1q con-
centration after DSW was significantly correlated with the changes in the upper thigh circumference (r = − 0.825, 
p = 0.002), BMD (r = − 0.929, p < 0.001), MVIC strength (r = − 0.837, p = 0.001) and 6 MW test results (r = − 0.873, 
p < 0.001); 3) the magnitude of increase in the plasma apelin concentration after DSW was significantly correlated 
with the changes in SBP (r = − 0.854, p = 0.001), DBP (r = − 0.783, p = 0.004) and 6 MW test results (r = 0.750, 
p = 0.006); and 4) the magnitude of changes in the plasma adropin concentration after DSW was significantly 
correlated with balance with EOFS (r = − 0.736, p = 0.008), glucose concentration (r = − 0.723, p = 0.009), HOMA 
index (r = − 0.713, p = 0.010), OGTT results (r = − 0.729, p = 0.008), TC concentration (r = − 0.863, p = 0.001) and 
HDLC concentration (r = 0.873, p < 0.001) (Table 3, Fig. 2). These results support the hypothesis and suggest that 
the greater training effects of DSW than ASW were associated with greater changes in plasma C1q, apelin and 
adropin concentrations between the baseline and post-training time points.
Watanabe and  colleagues13 reported a 39% decrease in the serum C1q concentration in older adults after 
12 weeks of bilateral resistance training of the knee flexors and extensors three times a week, which increased 
Table 3.  Multiple partial correlations (partial r and p values) between the normalised changes in plasma 
complement component 1q (C1q), apelin and adropin concentrations between before and after 12 weeks 
of descending stair walking (DSW) training and the normalised changes in resting heart rate (HR), systolic 
(SBP) and diastolic blood pressure (DBP), the maximal voluntary isometric contraction strength of the knee 
extensors (MVIC), 30-s chair-stand (CS), 2-min step (2MS), 6-m walk (6 MW), 6-m tendon walk (TW) test 
performance, balance with eyes open on firm surface (EOFS) and eyes closed on unstable surface (ECUS), 
upper thigh circumference (CIR), and bone mineral density (BMD) [upper table], and resting glucose (GLU) 
and insulin (INS) levels, the homeostasis model assessment (HOMA) index, whole blood glycosylated 
hemoglobin (HbA1c) concentration, oral glucose tolerance test (OGTT) results, total cholesterol (TC) 
concentration, triacylglycerol (TG) concentration, low- (LDLC) and high-density lipoprotein cholesterols 
(HDLC) concentrations [lower table] in the participants in the descending stair walking (DSW) group (n = 15). 
*: significant (p ≤ 0.01) correlation.
HR SBP DBP MVIC CS 2MS 6 MW TW EOFS ECUS CIR BMD
C1q
r .446 .614 .355 − .837* − .608 − .391 − .873* − .233 .703 .523 − .825* − .929*
p .098 .029 .157 .001 .031 .132  < .001 .259 .012 .061 .002  < .001
Apelin
r − .573 − .854* − .783* .565 .594 .211 .750* .279 − .407 − .696 .397 .591
p .042 .001 .004 .044 .035 .279 .006 .217 .122 .013 .128 .036
Adropin
r − .122 − .348 − .044 .413 .378 .216 .399 .025 − .736* − .578 .435 .526
p .368 .162 .452 .118 .141 .275 .127 .472 .008 .040 .104 .059
GLU INS HOMA HbA1c OGTT TG TC LDLC HDLC
C1q
r .332 .322 .416 .391 .447 .035 .417 .179 − .630
p .174 .182 .116 .132 .097 .462 .115 .310 .025
Apelin
r − .185 − − .483 − .406 − .360 − .426 − .316 − .446 − .119 .590
p .304 .079 .122 .153 .110 .187 .098 .371 .036
Adropin
r − .723* − .447 − .713* − .471 − .729* − .493 − .863* − .672 .873*
p .009 .098 .010 .085 .008 .074 .001 .017  < .001
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the MVIC strength of the muscles by 8–12% and the muscle cross-sectional area by 7%. The researchers stated 
that C1q was a novel biomarker of  sarcopenia13, and a potential role for C1q concentration in the development 
of collagen in bones has been  reported20. In the present study, 12 weeks of DSW training decreased the plasma 
C1q concentration by 51% (Fig. 1a) and increased MVIC strength and BMD by 34% and 6%, respectively. It is 
interesting that the magnitude of decrease in the C1q concentration in the blood and increase in muscle strength 
and BMD seemed to be greater after DSW than after resistance training in the aforementioned  study13, in which 
the intensity of eccentric contractions performed in the resistance training protocol was likely to be higher than 
that in the DSW training protocol. However, the total number of eccentric contractions performed by each 
leg during the training period was much greater in the DSW training protocol than in the resistance training 
protocol. It may be that not only the intensity but also the number of eccentric contractions causes the decrease 
in the C1q concentration in the blood after DSW training. Since the same number of concentric contractions 
Figure 2.  Scatter plot graphs for some selected strong correlations in Table 1. Partial correlations between 
complement component 1q (C1q) concentration and the maximal voluntary isometric contraction strength of 
the knee extensors (∆MVIC) (a), upper thigh circumference (∆CIR) (b), apelin concentration and systolic blood 
pressure (∆SBP) (c), diastolic blood pressure (∆DBP) (d), adropin concentration and oral glucose tolerance test 
(∆OGTT) results (e), and high-density lipoprotein cholesterols concentration (∆HDLC) (f) for the participants 
in the descending stair walking (DSW) group (n = 15).
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performed in the ASW training protocol did not decrease the plasma C1q concentration, it seems likely that 
eccentric contractions were responsible for the decrease in the plasma C1q concentration in the present study.
The magnitude of the increase in the plasma apelin concentration after DSW was 23% (Fig. 1b). A previous 
study reported a significant decrease in the apelin concentration (− 30%) after 8 weeks of aerobic exercise training 
[50–70% of the maximal heart rate  (HRmax)] in obese adult  women21; however, other  studies16,17,22 have shown 
significant increases in apelin concentration after aerobic exercise training. For example, Fujie and  colleagues22 
reported a 117% increase in the plasma apelin concentration after aerobic exercise training at 60–70% of the 
 VO2 peak three times a week for 8 weeks in middle-aged and older adults. Kadoglou and  colleagues16 found a 
39% increase in the serum apelin concentration after 12 weeks of aerobic exercise training four times a week for 
45–60 min per session in patients with T2DM. Afshounpour and  colleagues17 also reported that a combination 
of aerobic (50–75% of the maximal heart rate) and whole-body resistance exercise training (30–75% of 1-RM) 
increased the plasma apelin concentration by 29% in patients with T2DM. Thus, the magnitude of the increase 
in the plasma apelin concentration observed in the present study after DSW was comparable to that reported 
by Afshounpour and  colleagues17. It appears that metabolic demand during exercise is a factor affecting the 
increase in the apelin concentration in the blood. However, no increase in the plasma apelin concentration 
was evident after ASW, during which the HR was higher (114 bpm: ~ 74% of the  HRmax) than that during DSW 
(89 bpm: ~ 58% of the  HRmax). It may be that the intensity of ASW was too low to increase the plasma apelin 
concentration. It seems possible that eccentric contractions contribute to the increase in apelin concentration 
in the blood, probably through a different mechanism than aerobic factors. Apelin is involved in the regulation 
of eNOS gene expression and contributes to NO production in the endothelial cells of the  aorta23,24. It would be 
interesting to investigate changes in NO concentration after DSW in comparison to after ASW or other modes 
of eccentric exercises.
Regarding the plasma adropin concentration, the magnitude of increase was 127% after DSW, but the increase 
was not significant after ASW (Fig. 1c). It appears that the extent of the increase after the 12-week DSW inter-
vention was greater than that reported in previous  studies19,25. Fujie and  colleagues19 showed an 80% increase in 
the serum adropin concentration after 8 weeks of aerobic cycling training in middle-aged and older individu-
als. In contrast, two previous studies reported no significant increases in serum adropin concentrations after 
 acute26,27 and chronic aerobic exercise in healthy young men and middle-aged individuals, respectively. Zhang 
and  colleagues25 stated that serum adropin might underlie the improvement in endothelial function induced by 
aerobic exercise. It should be noted that the aerobic component of DSW was minimal, as indicated by the low 
HR of the participants during DSW (~ 58% of the  HRmax); however, the plasma adropin concentration more 
than doubled after DSW intervention, and no such increase was observed after ASW intervention (Fig. 1c). It 
is possible that eccentric contractions have a synergistic effect with aerobic exercise in increasing the adropin 
concentration in the blood after exercise training.
The magnitude of the decrease in the plasma C1q concentration and increase in the plasma apelin and adropin 
concentrations after DSW was strongly (r > 0.7 and p ≤ 0.01) correlated with the changes in some of the outcome 
measures (Table 3). A significant (p ≤ 0.01) correlation was found only between the magnitude of change in apelin 
concentration and DBP (r = − 0.732), CS (r = − 0.717), and HbA1c levels (r = 0.762) after ASW. After DSW, the 
C1q concentration changes were more strongly correlated with muscle and bone markers, the apelin concentra-
tion changes were more strongly associated with blood pressure, and the adropin concentration changes were 
related to insulin sensitivity and blood lipid profiles (Table 3).
The magnitude of the decrease in the plasma C1q concentration after DSW was strongly (r > 0.7 and p ≤ 0.01) 
correlated with the increase in MVIC strength, upper thigh circumference, BMD and 6 MW test results. It appears 
that skeletal muscle adaptations were associated with a decrease in the C1q concentration. Previous  studies12,13 
have reported that C1q expression in the blood is a marker of sarcopenia and that the greater the concentration 
of C1q is in the blood, the greater the extent of sarcopenia. Watanabe and  colleagues13 found that the decrease in 
the serum C1q concentration after 12 weeks of resistance training was significantly correlated with the increase 
in muscle cross sectional area in older adults and stated that the serum C1q concentration reflected the loss of 
muscle mass and strength upon ageing and responded to progressive resistance training. It is known that resist-
ance exercise elevates protein synthesis in muscles, activates satellite cells, promotes the cell cycle, and increases 
anabolic  action28,29. It is possible that DSW induced these changes and increased MVIC and muscle mass along 
with decreasing the plasma C1q concentration. Regarding apelin concentration, the magnitude of the increase in 
the plasma apelin concentration was highly (r > 0.7 and p ≤ 0.01) correlated with the decreases in resting SBP and 
DBP as well as 6 MW test results. Apelin is involved in many physiological processes, including the regulation 
of blood pressure and cardiac  function15,29. Pang and  colleagues30 reported that apelin administration reduced 
the systolic pressure of hypertensive rats, and Ishida and  colleagues23 showed that the hypotensive effect of 
apelin was mediated through the Akt/eNOS pathway. Andersen and  colleagues31 stated that apelin modulated 
eNOS expression, induced eNOS-dependent vasodilatation in the systemic and pulmonary circulation, and 
counteracted angiotensin-II-induced vasoconstriction. It has been documented that vasodilation mediated by 
NO in contracting muscles via increases in NO concentrations decreases blood  pressure32. It should be noted 
that the plasma apelin concentration did not change after ASW training; however, the HR and SBP were also 
decreased significantly after ASW training, although the magnitude of decrease was less than that after DSW 
training. It seems possible that apelin was not the only factor contributing to the improvements in HR and SBP 
induced by DSW training.
Regarding adropin concentration, the magnitude of changes in the plasma adropin concentration was strongly 
(r > 0.7 and p ≤ 0.01) correlated with balance with EOFS, insulin sensitivity (glucose concentration, HOMA index, 
OGTT results), and lipid profiles (TC and HDLC concentrations), as shown in Table 3. It is possible that adropin 
improved dyslipidaemia, glucose tolerance and insulin resistance through regulation of NO  bioavailability33,34. 
Shahjouei and  colleagues35 showed that adropin promoted glucose oxidation by decreasing the acetylation of 
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pyruvate dehydrogenase complex (PDHC), which is a rate-limiting factor for glucose oxidation, and down-
regulated the expression pyruvate dehydrogenase kinase-4 (PDK-4), which is a PDHC inhibitor. Several studies 
have demonstrated the roles of adropin in regulating glucose  metabolism36–41. Adropin has also been shown to 
regulate fuel selection in skeletal muscle to reduce fat oxidation while enhancing glucose  oxidation42,43. It may 
be that the descending stair walking intervention effects on improving insulin resistance, blood lipid profile, and 
cardiovascular health were related to increased blood flow and capillary density associated with the increased 
 adropin33. It is known that peroxisome proliferator-activated receptor gamma-activating factor 1 alpha (PGC-1α) 
affects the activity of carnitine palmitoyltransferase-1 (CPT-1) and PDK-4, which play key roles in the oxidation 
of fatty acids and glucose oxidation via the PDK  pathway44,45. Ghoshal and  colleagues46 reported that the plasma 
adropin concentration was inversely related to the plasma LDLC concentration in humans, suggesting a link 
with hepatic lipid metabolism. Thus, the large increase in adropin concentration after DSW may suggest that 
PGC-1α and its downstream pathways were more activated by DSW than ASW. It has also been documented that 
circulating adropin promotes the production of NO and increases NO bioavailability, which improves arterial 
stiffness after aerobic exercise  training22. However, no significant partial correlations were found between the 
increase in adropin concentration and the decrease in SBP in the present study (Table 3).
The mechanisms underlying the greater changes in plasma C1q, apelin and adropin concentrations after 
DSW training than after ASW training are not clear, but some speculations can be made. The main difference 
between DSW and ASW was the type of muscle contraction performed by the knee extensors; eccentric contrac-
tions were mainly performed during DSW, and concentric contractions were performed during  ASW7. It has 
been shown that eccentric contractions promote the anabolic signalling pathway (elevating protein synthesis 
in muscle, increasing the satellite cell number, and promoting the cell cycle) to a greater extent than concentric 
 contractions47,48. It should be noted that the intensity of eccentric contractions performed during DSW was 
lower than the maximal eccentric contraction strength. Samuel and  colleagues49 examined biomechanical func-
tional demand placed on the knee and hip muscles of older adults during DSW and ASW and reported that the 
functional demand relative to the MVIC strength of the knee extensors was greater during DSW (73%) than 
ASW (42%). D’Lima and  colleagues50 reported that the peak force of the knee extensors was 2.8 × body weight 
(BW) during walking, 2.8 × BW during ASW, 3.1 × BW during DSW, and 3.6 × BW during jogging. Eccentric 
loading during normal walking is approximately 25% of the MVIC strength of the knee  extensors51. Thus, the 
actual loading to the knee extensors during DSW and ASW does not appear to be largely different, but it seems 
possible that the type of muscle contraction of the knee extensors itself (eccentric vs concentric) rather than the 
force was the key factor contributing to the different changes in C1q, apelin and adropin concentrations between 
the DSW group and ASW group.
Myokines are cytokines and other peptides that are secreted from skeletal muscles, especially in response to 
exercise; these peptides function like hormones either locally within the muscle or by targeting distant  organs52. 
Apelin is classified as a myokine since it is produced and secreted not only by adipose tissue but also by skeletal 
muscle in response to  exercise53. Adropin is considered a neuropeptide since energy homeostasis-associated 
(ENHO) genes are abundant in the brain, including the ventromedial and lateral hypothalamic nuclei, which 
regulate appetite and autonomic  function54. Hepatic ENHO expression is associated with the expression of genes 
involved in glucose and lipid  metabolism54. The present study revealed that apelin and adropin concentrations 
increased only after DSW, during which eccentric contractions were mainly performed. Eccentric contractions 
can produce high levels of mechanical tension per active motor unit, stretch-induced strain, and a greater pro-
pensity for muscle damage than concentric  contractions55. It may be that eccentric contractions triggered the 
secretion of apelin and adropin by imposing greater mechanical stresses on muscle fibres, surrounding connective 
tissue, and capillaries and/or blood vessels. Further studies are needed to compare the effects of eccentric and 
concentric contractions on the secretion of myokines or neuropeptides.
Ageing is unavoidable, but decreases in physical function upon ageing can be attenuated by performing 
regular exercise, which is easier said than done. As the aged population increases worldwide, increasing health 
span is critical, and increasing physical activity and exercise is crucial. One of the barriers to physical activity 
is a lack of confidence in one’s ability to be physically active (low self-efficacy)56. As shown in the present study, 
the beneficial effects of DSW are encouraging to some people who are less fit and less confident in performing 
more physically demanding exercises. The significance of eccentric contractions in exercise prescription and the 
use of eccentric exercises such as DSW, downhill walking, or sitting to a chair slowly should be more strongly 
emphasised.
The present study had several limitations. First, the participants of the study were obese elderly women; thus, 
the results of the study may not generalize to young, adult and middle-aged men and women. Second, only 
plasma C1q, apelin and adropin concentrations were measured in the present study, and other parameters, such 
as well-known exercise-related biomarkers (blood adiponectin and leptin concentrations)57, were not evaluated 
in the present study. Third, the total number of participants in each group was 15, which was not appropriate 
for multiple regression analysis. It should also be noted that we did not control for the daily physical activity 
of the subjects during the experimentation, although we instructed and reminded the participants to maintain 
their normal daily lifestyles. Last, the present study was rather descriptive, and a mechanistic investigation of 
the factors affecting the changes in C1q, apelin and adropin concentrations following DSW was absent. Future 
studies considering these limitations and examining whether myokine and other biomarker responses are dif-
ferent following eccentric and concentric exercise are warranted.
In conclusion, the present study showed that the magnitude of changes in plasma C1q, apelin and adropin 
concentrations between pre- to post-training time points was greater in the DSW group than in the ASW group. 
It appears that the decrease in the plasma C1q concentration was more strongly associated with the increase 
in muscle and physical functions, that the increases in plasma apelin and adropin concentrations were more 
strongly associated with improvements in insulin sensitivity and lipid profiles, and that the increase in the 
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plasma apelin concentration was also associated with decreases in the resting HR and blood pressure as well as 
musculoskeletal and fitness. Further studies are required to investigate how greater changes in C1q, apelin and 
adropin concentration are induced by DSW intervention than by ASW intervention using a larger sample size.
Methods
Participants. We conducted secondary analyses of muscular, physical fitness, bone, cardiovascular, insulin 
sensitivity and lipid profile data from the previous intervention study in which older obese women performed 
descending (DSW) or ascending stair walking (ASW) training twice a week for 12 weeks. Thirty obese (body 
fat ≥ 30%) older (60–82 years old) women who had been sedentary provided informed consent to participate in 
the study, which was approved by the Joint Institutional Review Board of Taipei Medical University (approval 
#: 201502034). The participants were recruited from several Taipei City District health centres (Heihu, Shilin, 
Beitou). Their eligibility and suitability to participate in the study was determined by the International Physical 
Activity Questionnaire (IPAQ) and a health and medical questionnaire. An experienced orthopaedist checked 
the participant’s lower extremities to ensure that the participants had no knee or ankle problems, degenerative 
joint and muscle disease, or osteoarthritis that might be exacerbated by stair walking exercise. The participants 
were quasi-randomly divided into the DSW and ASW intervention groups (n = 15 per group) so that the average 
baseline MVIC strength of the knee extensors, age, body mass, and percent body fat were similar between the 
 groups7. Briefly, a maximum of eight participants were recruited at the same time, and they were ranked based 
on the MVIC strength, placed into one of the two groups by a lottery from the top pair to the bottom pair, to 
ensure that the baseline of MVIC strength was similar between the DSW and ASW groups. The sample size was 
estimated on the basis of an effect size of 1.0, an α-level of 0.05, and a power (1-β) of 0.80 for the possible dif-
ference in the increase in the MVIC strength of the knee extensors between the groups based on our pilot study 
using G*Power (G*Power 3.1.9.2; Heinrich-Heine-Universitat Dusseldorf, Dusseldorf, Germany). According 
to the analysis, 14 participants per group were necessary. Considering the possibility of participant dropout, 
15 participants per group were recruited. No significant differences in any of the physiological characteristics 
were observed between the DSW (mean ± standard deviation (SD): age, 65.4 ± 6.6 y; height, 154.9 ± 5.5 cm; body 
mass, 62.8 ± 5.1 kg; body mass index (BMI), 26.2 ± 1.1; percent body fat, 36.4 ± 3.3%) and ASW (age, 67.5 ± 7.1 y; 
height, 155.6 ± 6.2 cm; body mass, 62.7 ± 6.4 kg; BMI, 26.1 ± 0.8; percent body fat, 34.6 ± 5.3%) groups at baseline.
Exercise intervention. The exercise intervention was described in a previous  study7. Briefly, all partici-
pants performed progressive exercise training on the stairs of a 10-story building twice a week for 12  weeks7. An 
elevator was used to take the participants in the DSW group from the first to sixth floor and to take those in the 
ASW group from the sixth to first floor. Thus, the DSW group did not walk up stairs, and the ASW group did not 
walk down stairs during the exercise intervention. The number of stairs from the first to the sixth floor was 110 
(five floors, 22 stairs per floor). The walking tempo was approximately 1 s per step; thus, to descend or ascend 110 
stairs, it took approximately 2 min. The exercise volume was gradually increased for both groups over 12 weeks 
by increasing the number of repetitions by two every week (i.e., first week, 2 repetitions per session; 12th week, 
24 repetitions per session)7. It took approximately 5 min to perform two repetitions, including the time waiting 
for and riding on the elevator, and the time taken to perform 24 repetitions was approximately 60 min, includ-
ing approximately 12 min waiting for the elevator or in the elevator. Thus, the intervention was an intermittent 
exercise during which an approximately 2-min walk followed by a 30-s rest was repeated.
During stair walking, HR was recorded with a Polar RS800CXN monitor (Polar Electro, Kempele, Finland), 
and SBP and DBP were measured using an automated sphygmomanometer (MS 150f., Rossmax International 
Ltd., Taipei, Taiwan) before, during (HR only) and immediately after each  session7,58.
Outcome measures. The participants were familiarised with the testing procedures a week before the first 
exercise session. The details of the familiarisation session and criterion measures were reported in a study by 
Chen and  colleagues7. Briefly, the criterion measures were height, body mass, percent body fat, resting HR, SBP, 
DBP, upper thigh circumference; right calcaneus bone mineral density (BMD), MVIC strength of the right knee 
extensors, performance in functional fitness tests for senior adults, including the 30-s chair stand (CS), 2-min 
step (2MS), 6-m walk (6 MW) and 6-m tandem walk (TW), and balance (balance with EOFS and ECUS) tests; 
levels of insulin sensitivity markers (resting glucose and insulin concentrations, HOMA index, HbA1c concen-
tration, OGTT results) and blood lipid profiles (TG, TC, HDLC, and LDLC concentrations)7,59.
The participants rested in the supine position for at least 10 min before measurement of HR, SBP, and DBP, 
and the measurements were taken while the participants were lying supine on a padded table. The calcaneal BMD 
of the right heel of each participant was assessed using a bone sonometer (CM-100; Furuno Electric Co., Hyogo, 
Japan). Speed of sound (m/s) was used as a quantitative ultrasound parameter determined by the width of the 
heel and time delay between initial transmission and subsequent receipt of sound  waves7,60.
Assessment of MVIC strength of the knee  extensors56,60–62; functional physical fitness tests for senior adults, 
i.e., the CS, 2MS, 6 MW, TW; and two balance tests (balance with EOFS and ECUS), which were carried out using 
a Biodex BioSway Portable Balance System (Model 950-460; Biodex Medical Systems, Shirley, NY, USA), were 
performed 3 days before the first training session to obtain baseline measures and 4 days after the last training 
session to evaluate the effects of the  training7. Resting HR, blood pressure, and upper thigh circumference were 
also measured at these time  points7.
Approximately 10 ml of blood and another 3 ml of blood for measuring HbA1c concentration were drawn 
from the cubital fossa region of the arm by the same standard venipuncture technique 3 days before the first 
training session and 4 days after the last training  session7. Five millilitres of venous blood (10 ml) was put in 
a vacutainer tube containing dipotassium ethylenediaminetetraacetic acid (Becton Dickinson and Company, 
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Plymouth, UK), and another 5 mL of blood was left in the original vacutainer tube with a serum separator and 
clotting activator (silica) (Becton Dickinson and Company, Plymouth, UK) for 30 min at room temperature 
and centrifuged (2000 rpm) for 10 min to obtain plasma and serum, respectively. Serum samples were used for 
insulin sensitivity measures (i.e., resting glucose and insulin concentrations, HOMA index, HbA1c concentra-
tion) and lipid profiles (serum TG, TC, LDLC and HDLC concentrations). The remaining plasma samples were 
stored at − 80 °C for analyses of C1q, apelin and adropin concentrations. For the OGTT, capillary blood samples 
were obtained from the fingertips of each participant using sterilised Softclix lancets (Roche Diabetes Care Ltd., 
Surrey England, UK) before and 30, 60, 90 and 120 min after consumption of a 75-g standard glucose drink, 
and blood glucose concentrations were measured with an analyser (Johnson & Johnson, Livingstone, Scotland, 
UK). The detailed procedures used for analyses of glucose, insulin, OGTT, HbA1c, HOMA, TG, TC, LDLC, and 
HDLC were described  previously7,63–65.
C1q, apelin and adropin concentrations. Plasma C1q, apelin and adropin concentrations were meas-
ured by enzyme-linked immunosorbent assay (ELISA) using commercially available kits [C1q: Human C1q 
ELISA Kit, GA-E0374HM, GenAsia Biotech Co., Ltd, Shanghai, China; apelin: Human AP12 ELISA Kit, GA-
E0024HM, GenAsia Biotech Co., Ltd, Shanghai, China; adropin: Human Adropin (ENHO) ELISA Kit, CSB-
EL007669HU, CUSABIO®, Wuhan, China] according to the instructions of the manufacturer. The detection 
limits of the plasma C1q, apelin and adropin assays were 0.156–10 ng/ml, 31.25–2,000 pg/ml and 1.56–100 pg/
ml, respectively. The reliability of the plasma C1q, apelin and adropin concentrations was checked by the coef-
ficient of variation (CV) and intraclass correlation (r), which were 3.9% (r = 0.953), 9.2% (r = 0.950) and 9.7% 
(r = 0.900) for plasma C1q, apelin and adropin, respectively.
Statistical analyses. The data were assessed by the Shapiro–Wilk test for normality and by the Levene test 
for the homogeneity of variance assumption. These tests showed that the data for all parameters were normally 
distributed, and the variance was assumed to be homogenous. The baseline values of all dependent variables 
before DSW and ASW training exercise bouts were compared by t-tests. Changes in the all measures and plasma 
C1q, apelin and adropin concentrations over time were compared between the DSW and ASW groups by mixed-
model two-way analysis of variance (ANOVA). When a significant interaction effect was found, Tukey’s post 
hoc test was performed. η2 was calculated as a measure of effect size and was classified as follows: ~ 0.02: small 
effect; ~ 0.13: medium effect; and > 0.26: large  effect66. The significance level was set at p ≤ 0.05 for all dependent 
variables. Partial correlation analyses controlling for possible confounding factors (age, height, body mass, BMI, 
and percent body fat) were used to assess the relationships between C1q, apelin or adropin concentrations and 
all other variables in the DSW and ASW groups. The significance level was set at p ≤ 0.01 for multiple partial 
correlation analyses based on the small sample size (n = 15) for each  group67. The data are presented as the 
mean ± SD.
Ethical statement. All methods in the study complied with the current guidelines, regulations and laws of 
Taiwan where the study was performed in accordance with the 1964 Helsinki declaration.
Ethical approval. All experimental protocols were approved by the Joint Institutional Review Board of 
Taipei Medical University (approval #: 201502034).
Informed consent document. A written informed consent was obtained from each participant of the 
study.
Data availability
All data generated or analysed during this study are included in this submitted manuscript, and the data of the 
current study are available from the corresponding author on reasonable request.
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